TrialLancet (London, England)2023

Lisocabtagene maraleucel in chronic lymphocytic leukaemia and small lymphocytic lymphoma (TRANSCEND CLL 004): a multicentre, open-label, single-arm, phase 1-2 study.

Tanya Siddiqi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.